These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12569391)

  • 1. Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.
    Aytac U; Sato K; Yamochi T; Yamochi T; Ohnuma K; Mills GB; Morimoto C; Dang NH
    Br J Cancer; 2003 Feb; 88(3):455-62. PubMed ID: 12569391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint.
    Aytac U; Claret FX; Ho L; Sato K; Ohnuma K; Mills GB; Cabanillas F; Morimoto C; Dang NH
    Cancer Res; 2001 Oct; 61(19):7204-10. PubMed ID: 11585756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors.
    Sato K; Aytac U; Yamochi T; Yamochi T; Ohnuma K; McKee KS; Morimoto C; Dang NH
    Br J Cancer; 2003 Oct; 89(7):1366-74. PubMed ID: 14520473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
    McVean M; Weinberg WC; Pelling JC
    Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G2 arrest in response to topoisomerase II inhibitors: the role of p53.
    Clifford B; Beljin M; Stark GR; Taylor WR
    Cancer Res; 2003 Jul; 63(14):4074-81. PubMed ID: 12874009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin.
    Yamochi T; Yamochi T; Aytac U; Sato T; Sato K; Ohnuma K; McKee KS; Morimoto C; Dang NH
    Cancer Res; 2005 Mar; 65(5):1973-83. PubMed ID: 15753397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
    Deming PB; Flores KG; Downes CS; Paules RS; Kaufmann WK
    J Biol Chem; 2002 Sep; 277(39):36832-8. PubMed ID: 12147700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C.
    Singh SV; Herman-Antosiewicz A; Singh AV; Lew KL; Srivastava SK; Kamath R; Brown KD; Zhang L; Baskaran R
    J Biol Chem; 2004 Jun; 279(24):25813-22. PubMed ID: 15073169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered cell cycle response of drug-resistant lung carcinoma cells to doxorubicin.
    O'Loughlin C; Heenan M; Coyle S; Clynes M
    Eur J Cancer; 2000 Jun; 36(9):1149-60. PubMed ID: 10854949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-dihydroxyvitamin D(3)-induced retardation of the G(2)/M traverse is associated with decreased levels of p34(cdc2) in HL60 cells.
    Harrison LE; Wang QM; Studzinski GP
    J Cell Biochem; 1999 Nov; 75(2):226-34. PubMed ID: 10502295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
    Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.
    Janss AJ; Maity A; Tang CB; Muschel RJ; McKenna WG; Sutton L; Phillips PC
    Neuro Oncol; 2001 Jan; 3(1):11-21. PubMed ID: 11305412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint.
    Jiang H; Luo S; Li H
    J Biol Chem; 2005 May; 280(21):20651-9. PubMed ID: 15790566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1.
    Chang KL; Kung ML; Chow NH; Su SJ
    Biochem Pharmacol; 2004 Feb; 67(4):717-26. PubMed ID: 14757171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.
    Hapke G; Yin MB; Wu J; Frank C; Rustum YM
    Int J Oncol; 2002 Nov; 21(5):1059-66. PubMed ID: 12370755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase.
    Roshak AK; Capper EA; Imburgia C; Fornwald J; Scott G; Marshall LA
    Cell Signal; 2000 Jun; 12(6):405-11. PubMed ID: 11202906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G2 block induced by DNA damage: a caffeine-resistant component independent of Cdc25C, MPM-2 phosphorylation, and H1 kinase activity.
    Barratt RA; Kao G; McKenna WG; Kuang J; Muschel RJ
    Cancer Res; 1998 Jun; 58(12):2639-45. PubMed ID: 9635591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1.
    Herman-Antosiewicz A; Kim YA; Kim SH; Xiao D; Singh SV
    Pharm Res; 2010 Jun; 27(6):1072-9. PubMed ID: 20143254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAPK/JNK regulates cdc2/cyclin B kinase through phosphorylation and inhibition of cdc25c.
    Goss VL; Cross JV; Ma K; Qian Y; Mola PW; Templeton DJ
    Cell Signal; 2003 Jul; 15(7):709-18. PubMed ID: 12742231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.